Citation Impact
Citing Papers
Toll-like receptors and their ligands control mesenchymal stem cell functions
2006
The Increase in Thyroid Cancer Incidence During the Last Four Decades Is Accompanied by a High Frequency of BRAF Mutations and a Sharp Increase in RAS Mutations
2013
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Regulatory T-cells in autoimmune diseases: Challenges, controversies and—yet—unanswered questions
2014
Hallmarks of Cancer: The Next Generation
2011 Standout
Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab
2015
Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer
2010
Chapter 2 PI3K/PTEN Signaling in Angiogenesis and Tumorigenesis
2009
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
2014 Standout
Photodynamic therapy of a 2-methoxyestradiol tumor-targeting drug delivery system mediated by Asn-Gly-Arg in breast cancer
2013
Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial
2015
Thyroid cancer
2016 Standout
Targeting VEGF signalling via the neuropilin co-receptor
2012
Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice
2019
Hepatocellular carcinoma
2018 Standout
Bone marrow transplantation for sickle cell anemia: Progress and prospects
2004
Should All Papillary Thyroid Microcarcinomas Be Aggressively Treated?
2011
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation
2008
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
The grateful dead: damage‐associated molecular pattern molecules and reduction/oxidation regulate immunity
2007
Plant Phytochemicals as Epigenetic Modulators: Role in Cancer Chemoprevention
2013
Stem cell bioengineering for regenerative medicine
2004
Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences
2022 StandoutNobel
Mechanisms of disseminated cancer cell dormancy: an awakening field
2014
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
Variability in the Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: Sources and Recommendations
2011
Thyroid Gland Malignancies
2015
Measuring the multifaceted roles of mucin-domain glycoproteins in cancer
2022 StandoutNobel
Apigenin: A Promising Molecule for Cancer Prevention
2010 Standout
Plant flavonoid apigenin inactivates Akt to trigger apoptosis in human prostate cancer: an in vitro and in vivo study
2008
Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients
2008
SLAM Family Receptors Distinguish Hematopoietic Stem and Progenitor Cells and Reveal Endothelial Niches for Stem Cells
2005 Standout
Graft-versus-host disease
2009 Standout
Mortality due to cancer treatment delay: systematic review and meta-analysis
2020 Standout
The apoptotic effect of apigenin on human gastric carcinoma cells through mitochondrial signal pathway
2014
Apigenin inhibits proliferation of ovarian cancer A2780 cells through Id1
2009
Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase
2008
Systemic amyloidosis
2015 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis
2010
Evaluation of Statistical Designs in Phase I Expansion Cohorts: The Dana-Farber/Harvard Cancer Center Experience
2014
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
2008 StandoutNobel
Inhibition of HIF‐1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3‐M cells
2008
High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
2014 StandoutNobel
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches
2011
Aggressive Variants of Papillary Thyroid Cancer: Incidence, Characteristics and Predictors of Survival among 43,738 Patients
2011
Porous scaffold design for tissue engineering
2005 Standout
Applications of machine learning in drug discovery and development
2019 Standout
Tumor Spectrum, Tumor Latency and Tumor Incidence of the Pten-Deficient Mice
2007
Xanthohumol Impairs Human Prostate Cancer Cell Growth and Invasion and Diminishes the Incidence and Progression of Advanced Tumors in TRAMP Mice
2012
Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
2008 Standout
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study
2007
Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia
2004
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
2019 StandoutNature
Clinical pharmacokinetics of tyrosine kinase inhibitors
2009
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
2017 Nature
Can nanotechnology potentiate photodynamic therapy?
2012
Hepatocellular carcinoma
2022 Standout
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
2015 Standout
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Umbilical cord blood transplantation in adults: Results of the prospective cord blood transplantation (COBLT)
2005
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
2012
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
2013
Natural Polyphenols for Prevention and Treatment of Cancer
2016 Standout
Screening for Thyroid Cancer
2017
Isolating gene-corrected stem cells without drug selection
2005 StandoutNobel
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Regulatory T Cells and Human Disease
2020 StandoutNobel
Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft
2006
Oral Consumption of Green Tea Polyphenols Inhibits Insulin-Like Growth Factor-I–Induced Signaling in an Autochthonous Mouse Model of Prostate Cancer
2004
The Therapeutic Potential of Apigenin
2019 Standout
Cancer statistics in China, 2015
2016 Standout
Screening for Colorectal Cancer
2016 Standout
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
2012
Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase–Rearranged Anaplastic Thyroid Carcinoma
2014
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Induction of caspase-dependent extrinsic apoptosis by apigenin through inhibition of signal transducer and activator of transcription 3 (STAT3) signalling in HER2-overexpressing BT-474 breast cancer cells
2015
Markers of Response for the Antiangiogenic Agent Bevacizumab
2013
Metabolic reprogramming and cancer progression
2020 StandoutScience
Apigenin suppresses insulin‐like growth factor I receptor signaling in human prostate cancer: An in vitro and in vivo study
2008
Can We Prevent Prostate Cancer? Rationale and Current Status of Prostate Cancer Chemoprevention
2005
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
2011 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Modulation of Hematopoietic Stem Cell Homing and Engraftment by CD26
2004 Science
Apigenin and cancer chemoprevention: Progress, potential and promise (Review)
2007
Increasing thyroid cancer incidence in Q ueensland, A ustralia 1982–2008 – true increase or overdiagnosis?
2015
Apigenin induces apoptosis in human lung cancer H460 cells through caspase- and mitochondria-dependent pathways
2010
SERIES: Genomic instability in cancer Balancing repair and tolerance of DNA damage caused by alkylating agents
2012
Physiology of Microglia
2011 Standout
Works of Pingfu Fu being referenced
MET-Independent Lung Cancer Cells Evading EGFR Kinase Inhibitors Are Therapeutically Susceptible to BH3 Mimetic Agents
2011
Blockade of β-Catenin Signaling by Plant Flavonoid Apigenin Suppresses Prostate Carcinogenesis in TRAMP Mice
2007
Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non–Small Cell Lung Cancer
2018
MUC1 is expressed at high frequency in early-stage basal-like triple-negative breast cancer
2013
Apigenin Attenuates Insulin-Like Growth Factor-I Signaling in an Autochthonous Mouse Prostate Cancer Model
2011
Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults
2007
O6-benzylguanine and BCNU in multiple myeloma: a phase II trial
2007
Spontaneous Autologous Graft-versus-Host Disease in Plasma Cell Myeloma Autograft Recipients: Flow Cytometric Analysis of Hematopoietic Progenitor Cell Grafts
2011
Silicon phthalocyanine (pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial
2010
Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: In vitro and in vivo study
2011
Activation of PI3K‐Akt signaling pathway promotes prostate cancer cell invasion
2007
Nuclear Factor-κB/p65 (Rel A) Is Constitutively Activated in Human Prostate Adenocarcinoma and Correlates with Disease Progression
2004
Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA‐matched unrelated donor allogeneic transplantation in adults
2004
NRP-1/CD304 Expression in Acute Leukemia
2011
Progressive Proximal-to-Distal Reduction in Expression of the Tight Junction Complex in Colonic Epithelium of Virally-Suppressed HIV+ Individuals
2014
Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway
2013
Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry
2010
Peritransplant Use of Ultraviolet-B Irradiation (UV-B) Therapy Is Detrimental to Allogeneic Stem Cell Transplantation Outcome
2006
The Impact of Delayed Chemotherapy on Its Completion and Survival Outcomes in Stage II Colon Cancer Patients
2014
A Phase II Trial of Fosbretabulin in Advanced Anaplastic Thyroid Carcinoma and Correlation of Baseline Serum-Soluble Intracellular Adhesion Molecule-1 with Outcome
2009
Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid
2012
Impairment of Regulatory T-Cell Function in Autoimmune Thyroid Disease
2013
Erlotinib beyond progression study: Randomized phase II study comparing chemotherapy plus erlotinib with chemotherapy alone in EGFR tyrosine kinase inhibitor (TKI)-responsive, non-small cell lung cancer (NSCLC) that subsequently progresses.
2013
Suppression of Prostate Carcinogenesis by Dietary Supplementation of Celecoxib in Transgenic Adenocarcinoma of the Mouse Prostate Model
2004
Expansion of LTC‐ICs and Maintenance of p21 and BCL‐2 Expression in Cord Blood CD34+/CD38−Early Progenitors Cultured over Human MSCs as a Feeder Layer
2002
Multi-Institutional Phase I Trials of Anticancer Agents
2008
A Vasculature-Targeting Regimen of Preoperative Docetaxel with or without Bevacizumab for Locally Advanced Breast Cancer: Impact on Angiogenic Biomarkers
2009
Augmentation of umbilical cord blood (UCB) transplantation with ex vivo–expanded UCB cells: results of a phase 1 trial using the AastromReplicell System
2003
Differential Expression of S100A2 and S100A4 During Progression of Human Prostate Adenocarcinoma
2002
Toxicity results and early outcome data on a randomized phase II study of docetaxel ± bevacizumab for locally advanced, unresectable breast cancer
2006
Phase I and Pharmacokinetic Study of Imatinib Mesylate in Patients With Advanced Malignancies and Varying Degrees of Renal Dysfunction: A Study by the National Cancer Institute Organ Dysfunction Working Group
2008
Up‐regulation of insulin‐like growth factor binding protein‐3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice
2005